We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+16.38%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$71M
AUM Growth
+$26.4M
Cap. Flow
+$24M
Cap. Flow %
33.85%
Top 10 Hldgs %
86.77%
Holding
60
New
18
Increased
1
Reduced
6
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 66.73%
2 Materials 11.48%
3 Industrials 0.19%
4 Consumer Staples 0.16%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSPRZ
51
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
-48,000
Closed
SNGXW
52
DELISTED
Soligenix, Inc. Warrant
SNGXW
-16,599
Closed -$2K
UUUU.WS
53
DELISTED
Energy Fuels Inc.
UUUU.WS
$0 ﹤0.01%
277,777
APOPW
54
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
-12,498
Closed
ONTXW
55
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
-132,227
Closed -$3K
APDNW
56
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
-31,407
Closed
TEUM
57
DELISTED
Pareteum Corporation
TEUM
-955,486
Closed -$1.23M
SHIPW
58
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
-1,180,400
Closed -$12K

Similar funds

CVI Holdings's Q4 2019 Portfolio in Review

As of Q4 2019, CVI Holdings held 60 positions worth $71M, up 59% from $44.5M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

CVI Holdings deployed $24M of net new capital in Q4 2019, opening 18 new positions and adding to 1 existing holding. Its largest new stake was Abeona Therapeutics: 209,095 shares worth $17.1M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 39% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Notable Labs, Ltd. Ordinary Shares, an estimated $193K trimmed.

  • CVI Holdings's largest Q4 2019 buy was Abeona Therapeutics: 209,095 shares worth $17.1M.
  • CVI Holdings added most to Farmmi Inc in Q4 2019, an estimated $92.5K increase.
  • CVI Holdings's biggest Q4 2019 reduction was Notable Labs, Ltd. Ordinary Shares, cutting an estimated $193K.
  • CVI Holdings fully exited Carisma Therapeutics in Q4 2019, selling an estimated $5.54M.
  • CVI Holdings's ten largest holdings make up 87% of its $71M portfolio in Q4 2019.
  • CVI Holdings opened 18 new positions and closed 24 in Q4 2019.
  • CVI Holdings's portfolio value rose 59% quarter-over-quarter to $71M.

Based on CVI Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.